What is LOPJLB’s current signal on ELDN?

LOPJLB’s latest quantitative signal on Eledon Pharmaceuticals, Inc. (ELDN) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ELDN in?

Eledon Pharmaceuticals, Inc. (ELDN) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Eledon Pharmaceuticals, Inc. based / listed?

Eledon Pharmaceuticals, Inc. is based in US, listed on NASDAQ.

Eledon Pharmaceuticals, Inc. (ELDN)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.48+2.48%Close

SELLCRISIS · day 30

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $191M
Beta: 0.94
P/E (TTM): -2.47

Short % float: 14.41%
Days to cover: 8.8
SI change: -5.0%

1W: -0.40%
1M: -10.79%

vs SPY 1W: -1.56%
vs SPY 1M: -13.78%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell transplantation. Their flagship therapeutic…

Employees: 33
Headquarters: US
Founded: 2014
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 77.2M
Float: 90.8%

eledon.com ↗

Key executives

David-Alexandre C. Gros — Chief Executive Officer & Non Independent Director

Steven N. Perrin — President, Chief Scientific Officer & Non Independent Director

Paul Sean Little — Chief Financial Officer

SEC filings

EDGAR · CIK 14042810 · ELDN

Analyst consensus

Buy

Bullish4100.0%

Neutral00.0%

Bearish00.0%

L $5.00Avg $7.00H $9.00

Target$7.00+182.26%

Last$2.48

Key stats

Industry peers

Prediction markets

Company news